ananthapavan-ukbasedcost-2013.pdf (723.58 kB)
A UK based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
journal contribution
posted on 2013-06-01, 00:00 authored by D Price, Y Asukai, Jaithri AnanthapavanJaithri Ananthapavan, B Malcolm, A Radwan, I KeyzorA UK based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
History
Journal
Applied health economics and health policyVolume
11Issue
3Pagination
259 - 274Publisher
SpringerLocation
Berlin, GermanyPublisher DOI
Link to full text
ISSN
1175-5652eISSN
1179-1896Language
engPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2013, SpringerUsage metrics
Categories
No categories selectedKeywords
chronic obstructive pulmonary disease (COPD)bronchodilatorsUK National Health Service (NHS) perspectivecost effectivenessindacaterollong-acting beta2-agonist (LABA)tiotropiumsalmeterolSocial SciencesScience & TechnologyLife Sciences & BiomedicineEconomicsHealth Care Sciences & ServicesHealth Policy & ServicesBusiness & Economics
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC